Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?

Radiotherapy and Oncology

Volumn 85, Issue 2, 2007, Pages 178-186

  Girinsky, Theodore ^a   Ghalibafian, Mithra ^a   Bonniaud, Guillaume ^a   Bayla, Aziz ^a   Magne, Nicolas ^a   Ferreira, Ivaldo ^a   Lumbroso, Jean ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Clinical outcome; Dose painting; FDG PET; Hodgkin lymphoma; Involved node radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CERVICAL LYMPH NODE; CHEMOSENSITIVITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONCEPT FORMATION; CORRELATION ANALYSIS; DOSE PAINTING; DOSE RESPONSE; EARLY DIAGNOSIS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY LYMPH NODE; INVOLVED NODE RADIOTHERAPY; MALE; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIMULATION; SUBCARINAL LYMPH NODE; SUPRACLAVICULAR LYMPH NODE; TREATMENT OUTCOME; TUMOR VOLUME;

FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 36349025232     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.07.003     Document Type: Article

References (30)

1. Aleman B.M.P., van den Belt-Dusebout A.W., Klokman W.J., van't Veer M.B., Bartelink H., and van Leeuwen F.E. Long-term cause-specific mortality of patients treated for Hodgkin disease. J Clin Oncol 21 (2003) 3431-3439
2. Avril N., Menzel M., Dose J., et al. Glucose metabolism of breast cancer assessed by 18F-FDG FDG-PET: histologic and immunohistochemical tissue analysis. J Nucl Med 42 (2001) 9-16
3. Beachy P.A., Karhadkar S.S., and Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432 (2004) 324-331
4. Bhatia S., Robison L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin disease. New Engl J Med 334 (1996) 745-751
5. Bonniaud G, Isambert A, Coulot J et al. Is maximum intensity threshold segmentation a good tool for FDG-PET delineation in radiation therapy targeting? Int J Radiat Oncol Biol Phys, in press.
6. Burt B.M., Humm J.L., Kooby D.A., et al. Using positron emission tomography with [(18)F] FDG to predict tumor behaviour in experimental colorectal cancer. Neoplasia 3 (2001) 189-195
7. Daisne J.F., Sibomana M., Bol A., Cosnard G., Lonneux M., and Gregoire V. Tri-dimensional automatic segmentation of FDG-PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
8. Gallamini A., Rigacci L., Merli F., et al. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin disease. Haematologica 91 (2006) 475-481
9. Geets X., Daisne J.F., Arcangeli S., et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical cord: comparison between CT-scan and MRI. Radiother Oncol 77 (2005) 25-31
10. Girinsky T., van der Maazen R., Specht L., et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79 (2006) 270-277
11. Gregoire V. Is there any future in radiotherapy planning without the use of FDG-PET: unravelling the myth. Radiother Oncol 73 (2004) 261-263
12. Haioun C., Itti E., Rahmouni A., et al. [18F]Fluoro-deoxy-d-glucose positron emission tomography (FDG-FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 106 (2005) 1376-1381
13. Hancock S.L., Tucker M.A., and Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin disease. JAMA 270 (1993) 1949-1955
14. Hutchings M., Loft A., Hansen M., et al. FDG-FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107 (2006) 52-59
15. Hutchings M., Loft A., Hansen M., Berthelsen A.K., and Specht L. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Eur J Haematol 78 (2007) 206-212
16. Jerusalem G., and Beguin Y. The place of positron emission tomography imaging in the management of patients with malignant lymphoma. Haematologica 91 (2005) 442-444
17. Jordan C.T., Guzman M.L., and Noble M. Cancer stem cells. New Engl J Med 355 (2006) 1253-1261
18. Juweid M.E., Stroobants S., Hoekstra O.S., et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma. J Clin Oncol 25 (2007) 571-578
19. Koontz B., Kirkpatrick J., Clough R., et al. Combined modality therapy versus radiotherapy alone for treatment of early stage Hodgkin disease: cure versus complications. J Clin Oncol 24 (2006) 605-611
20. Krasin M.J., Hudson M.M., and Kaste S.C. Positron emission tomography in pediatric radiation oncology: integration in the treatment-planning process. Pediatr Oncol 34 (2004) 214-221
21. Lee Y.K., Cook G., Flower M.A., et al. Addition of 18F-FDG-FDG-PET scans to radiotherapy planning of thoracic lymphoma. Radiother Oncol 73 (2004) 277-283
22. Mauch P. Second malignancies after curative radiation therapy for good prognosis cancers. Int J Radiat Oncol Biol Phys 33 (1995) 959-960
23. Ng K., Bernardo M.P., Weller E., et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin disease treated at age 50 or younger. J Clin Oncol 20 (2002) 2101-2108
24. Paulino A.C., Koshy M., Howell R., Schuster D., and Davis L.W. Comparison of CT and FDG-FDG-PET defined gross tumor volume in intensity-modulated radiotherapy for head-and- neck cancer. Int J Rad Oncol Biol Phys 61 (2005) 1385-1392
25. Pugachev A., Ruan S., Carlin S., et al. Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62 (2005) 545-553
26. Tateishi U., Nishihara H., Tsukamoto E., Morikawa E., Tamaki N., and Miyasaka K. Lung tumors evaluated with FDG-FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr 26 (2002) 185-190
27. van Leeuwen F.E., Klokman W.J., Stovall M., et al. Role of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin disease. J Natl Cancer Inst 95 (2003) 971-980
28. Vesselle H., Schmidt R.A., Pugsley J.M., et al. Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6 (2000) 3837-3844
29. Wang D., Schultz C.J., Jursinic P.A., et al. Initial experience of FDG-PET/CT guided IMRT of head-and -neck carcinoma. Int J Rad Oncol Biol Phys 65 (2006) 143-151
30. Zasadny K.R., Tatsumi M., and Wahl R.L. FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers. Eur J Nucl Med Mol Imaging 30 (2003) 274-280